UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): June 30, 2004
ENDOCARE, INC.
Delaware
(State or other jurisdiction of incorporation)
| 0-27212 | 33-0618093 | |
| (Commission File Number) | (IRS Employer Identification No.) |
201 Technology Drive, Irvine, California 92618
(Address of principal executive offices, including zip code)
(949) 450-5400
(Registrant’s telephone number, including area code)
| ITEM 5. OTHER EVENTS | ||||||||
| ITEM 7. FINANCIAL STATEMENTS AND EXHIBITS | ||||||||
| SIGNATURES | ||||||||
| Exhibit Index | ||||||||
| EXHIBIT 99.1 | ||||||||
ITEM 5. OTHER EVENTS
On June 30, 2004, Endocare, Inc. issued a press release (the “Press Release”) announcing its receipt of a “Wells Notice” from the Securities and Exchange Commission. A copy of the Press Release is attached as Exhibit 99.1 to this Current Report on Form 8-K.
ITEM 7. FINANCIAL STATEMENTS AND EXHIBITS.
| (c) | Exhibits. |
| 99.1 | Press Release, dated June 30, 2004. |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report on Form 8-K to be signed on its behalf by the undersigned hereunto duly authorized.
| ENDOCARE, INC. |
||||
| By: | /s/ William J. Nydam | |||
| Date: June 30, 2004 | William J. Nydam | |||
| President & Chief Operating Officer | ||||
2